KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Common Equity (2016 - 2026)

Bausch Health Companies' Common Equity history spans 18 years, with the latest figure at -$1.1 billion for Q1 2026.

  • On a quarterly basis, Common Equity fell 350.83% to -$1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.1 billion, a 350.83% decrease, with the full-year FY2025 number at -$554.0 million, up 56.68% from a year prior.
  • Common Equity hit -$1.1 billion in Q1 2026 for Bausch Health Companies, down from -$554.0 million in the prior quarter.
  • Over the last five years, Common Equity for BHC hit a ceiling of $433.0 million in Q3 2022 and a floor of -$1.3 billion in Q4 2024.
  • Historically, Common Equity has averaged -$140.6 million across 5 years, with a median of -$141.0 million in 2022.
  • Biggest five-year swings in Common Equity: skyrocketed 864.71% in 2022 and later tumbled 1459.76% in 2024.
  • Tracing BHC's Common Equity over 5 years: stood at $260.0 million in 2022, then crashed by 131.54% to -$82.0 million in 2023, then tumbled by 1459.76% to -$1.3 billion in 2024, then skyrocketed by 56.68% to -$554.0 million in 2025, then plummeted by 95.31% to -$1.1 billion in 2026.
  • Business Quant data shows Common Equity for BHC at -$1.1 billion in Q1 2026, -$554.0 million in Q4 2025, and $356.0 million in Q3 2025.